Table 2.

Fasting parameters during the treatment period in placebo and rimonabant groups

	Week 0	Week 2	Week 6	Week 12	Week 16
Placebo
Glucose, mg/dl	95 ± 2.1	90 ± 1	92 ± 1	94 ± 2	91 ± 2
Insulin, pM	72 ± 13	67 ± 8	67 ± 11	69 ± 15	72 ± 15
FFA, mM	0.67 ± 0.05	0.65 ± 0.04	0.78 ± 0.07	0.79 ± 0.05	0.76 ± 0.05
Rimonabant
Glucose, mg/dl	96 ± 2	95 ± 2	93 ± 2	97 ± 2	93 ± 3
Insulin, pM	62 ± 3	68 ± 9	64 ± 8	77 ± 10	63 ± 10
FFA, mM	0.70 ± 0.06	0.81 ± 0.0	0.76 ± 0.06	0.68 ± 0.04	0.71 ± 0.06

Values are means ± SE.